Intervention

Impedance cardiography

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions7

Lead sponsors shown3

Clinical trials

3 shown

Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.NCT06277388 · 2021-06-05

ACTIVE_NOT_RECRUITING

Significance of Impedance Cardiography and Early Repolarization Pattern in ECG in Congestive Heart FailureNCT05480345 · 2019-12-20

COMPLETED

Non Invasive Measurement of Cardiac Index by Impedance CardiographyNCT01607515 · 2012-03-01

COMPLETED

Common conditions

Cardiac Toxicity1 Chronic Heart Failure1 Congestive Heart Failure1 Heart Failure1 Non-small Cell Lung Cancer1 Pulmonary Hypertension1 Right Ventricular Failure1

Leading sponsors

Lithuanian University of Health Sciences1 Medical University of Graz1 Sun Yat-sen University1

Trial status mix

COMPLETED2

ACTIVE_NOT_RECRUITING1

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.